MRA Advisory Group’s Eli Lilly LLY Stock Holding History

MRA Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$350K	Sell	292 -739	-72%	-$755K	0.13%	104
2026 Q1	$949K	Buy	1,031 +45	+5%	+$45.6K	0.39%	48
2025 Q4	$1.06M	Buy	986 +147	+18%	+$141K	0.44%	38
2025 Q3	$640K	Sell	839 -135	-14%	-$100K	0.28%	53
2025 Q2	$760K	Buy	974 +109	+13%	+$84.7K	0.36%	38
2025 Q1	$714K	Sell	865 -665	-43%	-$553K	0.38%	35
2024 Q4	$1.18M	Buy	1,530 +351	+30%	+$291K	0.63%	28
2024 Q3	$1.04M	Sell	1,179 -137	-10%	-$123K	0.57%	27
2024 Q2	$1.19M	Buy	1,316 +140	+12%	+$112K	0.68%	24
2024 Q1	$915K	Buy	1,176 +328	+39%	+$233K	0.55%	26
2023 Q4	$495K	Buy	+848	New	+$495K	0.33%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MRA Advisory Group's LLY Position: Q2 2026 in Review

MRA Advisory Group reduced its Eli Lilly (LLY) stake by 72% in Q2 2026, selling an estimated $755K and leaving 292 shares worth $350K. The position accounts for 0.13% of the portfolio, ranked #104.

MRA Advisory Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.19M in Q2 2024. 1,564 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

MRA Advisory Group held 292 shares of Eli Lilly worth $350K as of Q2 2026.
MRA Advisory Group sold 739 Eli Lilly shares in Q2 2026, an estimated $755K.
Eli Lilly made up 0.13% of MRA Advisory Group's portfolio in Q2 2026, its #104 holding.
MRA Advisory Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
MRA Advisory Group's Eli Lilly position peaked at $1.19M in Q2 2024.
1,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.